Invitations to Participate in Clinical Studies and Trials.

We sponsor independent clinical studies and trials for the African Bitter Root Supplement for both sickle cell disease treatment and osteoarthritis treatment.

Clinicians wishing to participate in clinical trials, or act as a Principal Investigator to run their own trials of the supplement, are invited to contact us for a full information pack, access to our eCTD data, and contact with our independent Chief Investigator.

We are unable to engage directly with members of the public, but if you wish to partipate and are in the UK or Europe, ask your doctor to contact us to enrol his centre.

Anugel(™) Surgical Dressings proven to delivery large benefits in patient comfort following haemorrhoid surgery

Anugel(™) is a new type of surgical dressing that was tested against existing haemostatic gelatinous sponge dressings in a randomised clinical trial on 110 patients. The trial found that Anugel(™) cuts the need for analgesics following surgery to remove Class 3 and 4 haemorrhoids, by 33% and reduces pain as measured on the VAS scale by 60%. Anugel(™) delivers a huge improvement in patient comfort. Details of the trial is being submitted for publication in major journals.

Study of a promising treatment alleviating arthritis

Our investigators observed that the African food supplement we are investigating for sickle cell treatment, is used traditionally by those with arthritis. This use was discounted initially, as our focus was on sickle cell disease. However, when chemical analysis identified the active compounds in the African Bitter Root plant involved, one group was recognised as having potential for use with arthritis. Deep Life Medical are sponsoring an independent clinical study on participants having from mild osteoarthritis to severe rheumatoid arthritis.
If you are a GP or a Consultant in a UK hospital, and wish your centre to participate, contact us for an information pack, and contact to the independent Principal Investigator for this study.

Study of a traditional Sickle Cell treatment

Deep Life are sponsoring independent clinical studies and trials on African Bitter Root Supplement.

The treatment is the root bark of single African plant used traditionally as a food supplement, combined with a buffer: it is not an opioid or analgesic but is thought to relieve the symptoms by allowing cells to slide over each other more easily.
If you are a GP or a Consultant in a European hospital, and wish your centre to participate, contact us for an information pack, and contact with the independent Principal Investigator for this trial.